Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics
Year: 2014
Type: article
Study design: Observational Study
Source: Cancer Cytopathology
DOI: 10.1002/cncy.21474
Institutions: UPMC Presbyterian, University of Pittsburgh Medical Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2142795623
